Announcements Trials
Browse Landscape

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 62Observational 2

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 2Breast 2Dermatologic 1

Conditions

SCLC, Extensive Stage 1Lung Neoplasms 1

Interventions

Blood Specimen Collection 53Surveys and Questionnaires 30Drug Therapy 27Immunotherapy 25Surgical Procedures, Operative 22Carboplatin 22Nivolumab 21Immune Checkpoint Inhibitors 20pembrolizumab 18osimertinib 18atezolizumab 17Observation 17Radiotherapy 16Bevacizumab 15Cisplatin 14Afatinib 14Specimen Handling 13Gene Expression Profiling 13Erlotinib Hydrochloride 13lorlatinib 12Pemetrexed 12Magnetic Resonance Spectroscopy 11Ipilimumab 11Immunohistochemistry 11Biopsy 11durvalumab 10alectinib 10Paclitaxel 10Bronchoscopy 10Tomography, X-Ray Computed 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × toripalimab × Thoracic × Clear all
NCT07308379 2025-12-29

Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer

Fudan University

Not yet recruiting
1,200 enrolled
Thoracic

SCLC, Extensive Stage

NCT05652712 2022-12-15

A Real-World Study of Toripalimab in Chinese Patients With Lung Cancer(THUNDER Study)

Qianfoshan Hospital

Unknown
200 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡